Dow Down0.47% Nasdaq Down0.26%

Prosensa Holding N.V. (RNA)

8.33 Up 0.04(0.48%) 1:07PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Prosensa Holding N.V.
J.H. Oortweg 21
Leiden, 2333 CH
Netherlands - Map
Phone: 31 71 332 2100
Fax: 31 71 332 2088

Index Membership:N/A
Full Time Employees:89

Business Summary 

Prosensa Holding N.V., a biotechnology company, engages in the discovery and development of ribonucleic acid-modulating therapeutics for the treatment of genetic disorders. The company’s products focus on the treatment of neuromuscular and neurodegenerative disorders, including duchenne muscular dystrophy (DMD), myotonic dystrophy, and huntington’s diseases. It develops drisapersen, which is in Phase III studies to restore dystrophin expression and enhancing muscle condition; PRO044 that is in Phase I/II studies to address a separate sub-population of DMD patients; and PRO045, PRO053, PRO052, and PRO055 to address other distinct sub-populations of DMD patients. The company also develops PRO135 that is in preclinical trials for myotonic dystrophy; PRO289, which is in preclinical trials for treating huntington’s diseases; and PROSPECT for the rare mutations. Prosensa Holding N.V. was incorporated in 1997 and is based in Leiden, the Netherlands.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Prosensa Holding N.V.

Key Executives 
Mr. Hans G. C. P. Schikan , 56
Chief Exec. Officer and Member of Management Board
Dr. Herman A. de Boer Ph.D.,
Co-Founder and Scientific Director
Mr. Gerard Platenburg ,
Founder, Chief Devel. Officer and Member of Scientific & Clinical Advisory Board
Mr. Berndt A. E. Modig MBA, CPA, 55
Chief Financial Officer, Principal Accounting Officer and Member of Management Board
Mr. Luc M. A. Dochez , 40
Chief Bus. Officer, Sr. VP of Bus. Devel. and Member of Management Board
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.